San Diego-based Illumina (NASDAQ: [[ticker:ILMN]]), the world’s biggest maker of high-speed gene sequencing machines, has made another equity investment in U.K-based Oxford Nanpore. Oxford said today it has raised $41 million (25 million pounds) from Lansdowne Partners, IP Group, Invesco Perpetual, Redmile Group, Illumina and other undisclosed investors. Illumina first invested in Oxford, and its new method for DNA sequencing, in January 2009, and made its second investment in February 2010.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
